Catalyst Wire Dossier Catalyst Wire Dossier

PA32540

aspirin/omeprazole · Pozen, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PA32540, covering 2008-03-10 to 2016-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers [Phase 3]

See pricing